No increase of IgA production at the day of second dose (median 21d) or 14-28 days after second dose was observed in the vaccinated individuals. In contrast, most COVID-19 patients had detectable salivary IgA towards after 15-30 days after the onset of symptoms. Here, CD79A is linked to COVID-19.